Literature DB >> 17434909

Evaluation of a 1,25-dihydroxyvitamin D enzyme immunoassay.

Isolde Seiden-Long1, Reinhold Vieth.   

Abstract

BACKGROUND: Radioactive reagents are used in most assays for measurement of 1,25-dihydroxyvitamin D [1,25(OH)(2)D]. We evaluated a 1,25(OH)(2)D enzyme immunoassay (EIA) from IDS Ltd. that uses solid-phase immunoextraction and colorimetric detection and compared results to those of the thymus radioreceptor assay (RRA) for 1,25(OH)(2)D.
METHODS: We collected serum samples (n = 145) representing an even distribution (0-200 pmol/L) of 1,25(OH)(2)D concentrations and Vitamin D External Quality Assessment Scheme (DEQAS) proficiency survey samples from 2004 surveys (n = 15) and stored them at -20 degrees C. We analyzed all samples with both EIA and RRA methods. We calculated imprecision using 5 QC samples in quadruplicate in each run (n = 6), including both pooled patient material used for QC with the RRA and QC material included in the EIA reagent set. We evaluated calibration stability by analyzing calibrators from different lots on the same plate and determining if calculated sample values drifted significantly.
RESULTS: Deming linear regression between IDS EIA and RRA methods yielded slope 1.25 (95% CI 1.13-1.37), y-intercept -3 (95% CI -18 to 12), R(2) = 0.74. DEQAS proficiency survey samples for 2004 were all within 30% of the all-methods-trimmed mean. Imprecision CVs were 12%-16% within-run and 15%-20% between-run.
CONCLUSIONS: We find no evidence of inferiority to the classic calf-thymus receptor assay for 1,25(OH)(2)D and no disadvantage in the results generated by the IDS EIA using samples from the major proficiency survey for 1,25(OH)(2)D. According to the product insert, however, the IDS EIA underestimates 1,25(OH)(2)D(2) compared with the D(3) form.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17434909     DOI: 10.1373/clinchem.2006.077560

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  6 in total

1.  Vitamin D and Cardiovascular Disease: Can Novel Measures of Vitamin D Status Improve Risk Prediction and Address the Vitamin D Racial Paradox?

Authors:  Samuel M Kim; Pamela L Lutsey; Erin D Michos
Journal:  Curr Cardiovasc Risk Rep       Date:  2017-01-21

2.  A new sensitive LC/MS/MS analysis of vitamin D metabolites using a click derivatization reagent, 2-nitrosopyridine.

Authors:  Debin Wan; Jun Yang; Bogdan Barnych; Sung Hee Hwang; Kin Sing Stephen Lee; Yongliang Cui; Jun Niu; Mitchell A Watsky; Bruce D Hammock
Journal:  J Lipid Res       Date:  2017-02-01       Impact factor: 5.922

3.  Quantification of 1α,25-dihydroxy vitamin D by immunoextraction and liquid chromatography-tandem mass spectrometry.

Authors:  Frederick G Strathmann; Thomas J Laha; Andrew N Hoofnagle
Journal:  Clin Chem       Date:  2011-07-18       Impact factor: 8.327

Review 4.  Vitamin D Assays.

Authors:  Daniel D Bikle
Journal:  Front Horm Res       Date:  2018-03-29       Impact factor: 2.606

5.  Low Bioactive Vitamin D Is Associated with Pregnancy-Induced Hypertension in a Cohort of Pregnant HIV-Infected Women Sampled Over a 23-Year Period.

Authors:  Kristi R Van Winden; Allison Bearden; Naoko Kono; Toni Frederick; Eva Operskalski; Alice Stek; Raj Pandian; Lorayne Barton; Andrea Kovacs
Journal:  Am J Perinatol       Date:  2019-07-31       Impact factor: 3.079

6.  Low maternal vitamin D is associated with increased risk of congenital and peri/postnatal transmission of Cytomegalovirus in women with HIV.

Authors:  Allison Bearden; Kristi Van Winden; Toni Frederick; Naoko Kono; Eva Operskalski; Raj Pandian; Lorayne Barton; Alice Stek; Andrea Kovacs
Journal:  PLoS One       Date:  2020-02-13       Impact factor: 3.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.